Muscular dystrophy is a group of muscle diseases which is characterized by progressive muscle weakness and breakdown of muscle mass over time. In this condition, mutated or abnormal genes interfere with the production of protein i.e. dystrophin, which is helpful for the formation of healthy muscle. The most common type is Duchenne muscular dystrophy (a severe form and mainly affects males), followed by Becker muscular dystrophy (a less severe form and mainly affects the voluntary muscles). Read More
Adi Intellect
Related Articles
Roger 2023-12-29
The Muscular Dystrophy Treatment Market is estimated for 2023 for the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Additionally, increasing research activities for developing new treatment options is another major factor driving the muscular dystrophy treatment market. Increased government initiatives for muscular dystrophy treatmentMany governments across the globe have launched funding programs and initiatives aimed at funding research for developing new treatments for muscular dystrophy. The increased governmental focus on treatment development is expected to significantly drive growth in the muscular dystrophy treatment market in the coming years. Increasing adoption of new treatment paradigmsAdvancements in understanding disease mechanisms of different muscular dystrophies have opened up new treatment paradigms that target specific molecular pathways driving the pathology.
0
Omkar Patel 2024-02-21
The global muscular dystrophy treatment market is primarily driven by the increasing research investments in gene and cell therapies. For instance, Sarepta Therapeutics' Vyondys 53 is the first FDA-approved therapy targeting the underlying cause of Duchenne muscular dystrophy. The Global muscular dystrophy treatment market is estimated to be valued at US$ 2. According to Parent Project Muscular Dystrophy estimates, over 300,000 people in the United States and many millions worldwide are affected by some form of muscular dystrophy. North America currently dominates the muscular dystrophy treatment market in terms of value.
0
Anjali CMI 2023-08-25
Economic: The economic factors influencing the Duchenne Muscular Dystrophy Treatment Market include healthcare expenditure, affordability of therapies, and insurance coverage. North America is expected to dominate the Duchenne Muscular Dystrophy Treatment Market due to the presence of major pharmaceutical companies, supportive regulatory frameworks, and strong healthcare infrastructure. These companies focus on research and development activities, collaborations, and partnerships to advance the treatment options for Duchenne Muscular Dystrophy. In conclusion, the global Duchenne Muscular Dystrophy Treatment Market is projected to grow significantly over the forecast period. The increasing focus on gene therapy, favorable political and technological factors, along with the presence of key market players, will drive market growth.
0
saikiran TBRC 2024-04-01
Sizing and ForecastThe duchenne muscular dystrophy (dmd) therapeutics market size has grown exponentially in recent years. The duchenne muscular dystrophy (dmd) therapeutics market size is expected to see exponential growth in the next few years. The regions covered in duchenne muscular dystrophy (DMD) therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. Therefore, a rising number of clinical trials will drive the growth of the duchenne muscular dystrophy (DMD) therapeutics market. Key Industry PlayersMajor players in the duchenne muscular dystrophy (dmd) therapeutics market are CVS Health Corporation, Pfizer Inc.
0
Ankit Nigam 2022-01-18
DelveInsight's "Becker Muscular Dystrophy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Becker Muscular Dystrophy (BMD), historical and forecasted epidemiology as well as the Becker Muscular Dystrophy (BMD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some facts of Becker Muscular Dystrophy Market are:· According to the Genetic and Rare Diseases Information Center, the prevalence of BMD is estimated to be between 17–27 cases per million people. titled “Recent developments in Duchenne muscular dystrophy: facts and numbers”, the worldwide prevalence of BMD is estimated to be 1. com/report-store/becker-muscular-dystrophy-market Scope of the Becker Muscular Dystrophy Market Report· The report covers the descriptive overview of Becker Muscular Dystrophy (BMD), explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies· Comprehensive insight has been provided into the Becker Muscular Dystrophy (BMD) epidemiology and treatment in the 7MM· Additionally, an all-inclusive account of both the current and emerging therapies for Becker Muscular Dystrophy (BMD) is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape· A detailed review of the Becker Muscular Dystrophy (BMD) market; historical and forecasted is included in the report, covering drug outreach in the 7MM· The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Becker Muscular Dystrophy (BMD) marketSome Becker Muscular Dystrophy Companies are:· PTC Therapeutics· Italfarmaco· Epirium Bio· Edgewise Therapeutics· And Many OthersRequest for Sample Pages: https://www. com/report-store/becker-muscular-dystrophy-market Becker Muscular Dystrophy Drugs:· Translarna· Givinostat· EPM-01· EDG-5506· And Many Others
0
Naaz Khan 2022-05-28
The Duchenne Muscular Dystrophy Treatment Market report covers all the important information associated with the market such as target market size, share, current trends, challenges, restraints, competition analysis, and market potential during the forecast period of 2021 to 2028. Get more information on “Global Duchenne Muscular Dystrophy Treatment Market Research Report” by requesting FREE Sample Copy at https://www. Additionally, these tools also give an inclusive assessment of each segment in the global market of duchenne muscular dystrophy treatment. Browse Global Duchenne Muscular Dystrophy Treatment Market Research Report with detailed TOC at https://www. Purchase Complete Global Duchenne Muscular Dystrophy Treatment Market Research Report at https://www.
0
WHO TO FOLLOW